2008
DOI: 10.1021/ja805531w
|View full text |Cite
|
Sign up to set email alerts
|

Application of Affinity Selection/Mass Spectrometry to Determine the Structural Isomer of Parnafungins Responsible for Binding Polyadenosine Polymerase

Abstract: To discover antifungal treatments that possess the desired characteristics of broad spectrum activity, a strong safety profile, and oral bioavailability, new discovery strategies must be implemented to identify structural classes of molecules capable of combating these microorganisms. One such technique that has been implemented is the Candida albicans Fitness Test, a whole cell screening platform capable of delineating the mechanism of action of compounds that demonstrate activity against the clinically relev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 39 publications
0
19
0
Order By: Relevance
“…Applications of SEC AS‐MS to cancer drug discovery have included screening for ligands to cyclin dependent 2 and its cyclin A subunit, 47 screening 15 Nf‐κB pathway proteins for anti‐inflammation compounds, 50 and in an example of a target not amenable to conventional HTS and screening for inhibitors of the Myc oncogene that bind to the G‐quadruplex, a G‐rich DNA secondary structure found within the Myc promoter 51 . In an example of SEC AS‐MS for natural product drug discovery, a mixture of isomeric panafungins from Fusarium larvarum were screened for binding to the antifungal target polyadenosine polymerase 52 …”
Section: Size Exclusion Chromatography As‐msmentioning
confidence: 99%
See 1 more Smart Citation
“…Applications of SEC AS‐MS to cancer drug discovery have included screening for ligands to cyclin dependent 2 and its cyclin A subunit, 47 screening 15 Nf‐κB pathway proteins for anti‐inflammation compounds, 50 and in an example of a target not amenable to conventional HTS and screening for inhibitors of the Myc oncogene that bind to the G‐quadruplex, a G‐rich DNA secondary structure found within the Myc promoter 51 . In an example of SEC AS‐MS for natural product drug discovery, a mixture of isomeric panafungins from Fusarium larvarum were screened for binding to the antifungal target polyadenosine polymerase 52 …”
Section: Size Exclusion Chromatography As‐msmentioning
confidence: 99%
“…51 In an example of SEC AS-MS for natural product drug discovery, a mixture of isomeric panafungins from Fusarium larvarum were screened for binding to the antifungal target polyadenosine polymerase. 52 Following the approach originally reported by the van Breemen laboratory using PUF AS-MS, 16 researchers at Merck used SEC AS-MS to screen combinatorial chemical analogs in an unpurified reaction product mixture for binding to a target protein. 53 In one example, 19 compounds were prepared in one reaction vessel using amide coupling and screened without purification for binding to ERK2.…”
Section: Size Exclusion Chromatography As-msmentioning
confidence: 99%
“…It was observed by affinity selection/mass spectrometry that the "straight" isomer, assigned as parnafungin A, binds with higher affinity to polyadenosine polymerase (PAP) compared to the "bent" structures of other parnafungins. 169 The marine sponge secondary metabolite bromobenzisoxazolone barettin 22 was identied as an antifouling agent, as it inhibits the settlement (EC 50 ¼ 15 nM) of barnacle larvae (Balanus improvisus). 9 The efficiency of this inhibition is about 60 times more potent than that of isolated structural analogues, which lack the benzisoxazolinone moiety.…”
Section: Toxicology Of Isoxazolin-5-one Derivativesmentioning
confidence: 99%
“…Additionally, the parnafungins (A−D) are a further group of natural products containing the structural motif of tetrahydroxanthones. Two representatives, parnafungin A and B, have been isolated from the fermentation extract of F. larvarum in 2008.…”
Section: Introductionmentioning
confidence: 99%